Found: 29
Select item for more details and to access through your institution.
Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 9, p. 1, doi. 10.1007/s00520-024-08828-1
- By:
- Publication type:
- Article
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1755, doi. 10.1007/s10637-020-00936-z
- By:
- Publication type:
- Article
The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.639745
- By:
- Publication type:
- Article
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 260, doi. 10.1159/000498985
- By:
- Publication type:
- Article
Investigational agents in metastatic basal cell carcinoma: focus on vismodegib.
- Published in:
- Journal of Experimental Pharmacology, 2012, v. 4, p. 97, doi. 10.2147/JEP.S26591
- By:
- Publication type:
- Article
Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2018, v. 53, n. 3, p. 656, doi. 10.1093/ejcts/ezx406
- By:
- Publication type:
- Article
Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
First-line treatment of advanced ALK-positive non-small-cell lung cancer.
- Published in:
- Lung Cancer: Targets & Therapy, 2015, v. 6, p. 71, doi. 10.2147/LCTT.S63491
- By:
- Publication type:
- Article
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21619-0
- By:
- Publication type:
- Article
Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 65, doi. 10.1002/cncr.33885
- By:
- Publication type:
- Article
First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel.
- Published in:
- International Journal of Nanomedicine, 2014, v. 9, p. 209
- By:
- Publication type:
- Article
A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients With Advanced Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 24, p. 5686, doi. 10.1002/cncr.25448
- By:
- Publication type:
- Article
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Understanding, recognizing, and managing toxicities of targeted anticancer therapies.
- Published in:
- CA: A Cancer Journal for Clinicians, 2013, v. 63, n. 4, p. 249, doi. 10.3322/caac.21184
- By:
- Publication type:
- Article
Concomitant Mediastinoscopy Increases the Risk of Postoperative Pneumonia After Pulmonary Lobectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 5, p. 1269, doi. 10.1245/s10434-018-6397-6
- By:
- Publication type:
- Article
Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options.
- Published in:
- Cancer Biology & Medicine, 2016, v. 13, n. 1, p. 77, doi. 10.20892/j.issn.2095-3941.2016.0008
- By:
- Publication type:
- Article
Tumor Characteristics and Treatment Responsiveness in Pembrolizumab-Treated Non-Small Cell Lung Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 744, doi. 10.3390/cancers16040744
- By:
- Publication type:
- Article
PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4789, doi. 10.3390/cancers15194789
- By:
- Publication type:
- Article
Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 675, doi. 10.3390/cancers12030675
- By:
- Publication type:
- Article
Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events.
- Published in:
- Cancers, 2017, v. 9, n. 7, p. 73, doi. 10.3390/cancers9070073
- By:
- Publication type:
- Article
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 7, doi. 10.1007/s00280-022-04443-1
- By:
- Publication type:
- Article
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 6, p. 522, doi. 10.1007/s00280-004-0950-7
- By:
- Publication type:
- Article
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 664, doi. 10.1111/cts.12928
- By:
- Publication type:
- Article
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.
- Published in:
- 2016
- By:
- Publication type:
- journal article